Keywords: ESMO, Roche, MetMAb, Sanofi-Aventis, Iniparib, Merck KGaA, Erbitix, Amgen, Denosumab, Eisai, Eribulin, Lung, Breast, Colorectal, Ovarian, Bone cancer

Strong cancer drug results presented by Roche, Sanofi-Aventis, Merck KGaA, Amgen and Eisai at ESMO Congress

Article | 12 October 2010

The 35th European Society of Medical Oncology congress, taking place in Milan, Italy, has seen a batch of clinical trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck KGaA

Amgen

Sanofi-Aventis

Roche

Eisai

Go to company listing

Related Drugs

denosumab

iniparib

MetMAb

Erbitux

eribulin

Go to drug listing